SynAct Pharma AB (SYNACT) — Financial Flexibility Index
SynAct Pharma AB (SYNACT) has a Financial Flexibility Index of -0.48x as of December 2025. Free cash flow of Skr-23.96 Million (operating CF Skr-23.96 Million minus capex Skr0.00) represents 0% of total liabilities (Skr50.23 Million). Also explore SYNACT net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SynAct Pharma AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for SynAct Pharma AB across 10 annual periods. Check how strategically is SynAct Pharma AB's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for SynAct Pharma AB (2016–2025)
Year-by-year free cash flow to debt coverage for SynAct Pharma AB. For the full company profile including market capitalisation, see SynAct Pharma AB (SYNACT) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.94x | Skr-97.33 Million | Skr-97.33 Million | Skr50.23 Million | ▼ -22.4% |
| 2024 | -1.58x | Skr-89.20 Million | Skr-89.20 Million | Skr56.35 Million | ▲ +18.1% |
| 2023 | -1.93x | Skr-100.18 Million | Skr-100.18 Million | Skr51.83 Million | ▲ +73.6% |
| 2022 | -7.31x | Skr-117.56 Million | Skr-117.56 Million | Skr16.08 Million | ▼ -96.9% |
| 2021 | -3.71x | Skr-65.00 Million | Skr-65.00 Million | Skr17.50 Million | ▼ -2126230.4% |
| 2020 | 0.00x | Skr-1.00K | Skr-33.24 Million | Skr5.72 Million | ▲ +100.0% |
| 2019 | -1.52x | Skr-15.62 Million | Skr-16.12 Million | Skr10.31 Million | ▲ +76.7% |
| 2018 | -6.52x | Skr-24.21 Million | Skr-24.21 Million | Skr3.72 Million | ▲ +11.0% |
| 2017 | -7.32x | Skr-16.94 Million | Skr-17.20 Million | Skr2.31 Million | ▼ -84.9% |
| 2016 | -3.96x | Skr-13.83 Million | Skr-14.73 Million | Skr3.49 Million | — |